ICON partners with Anthropic to integrate Claude AI into clinical trials
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
July 28, 2026 7:00 AM EDTDUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR) today announced a multi-year collaboration with Anthropic to bring Claudes AI capabilities across the clinical trial lifecycle. The collaboration further advances ICONs digital innovation and AI strategy, and builds on Orbis ICONs secure, governed, agentic AI platform.
Through this collaboration, ICON will work closely with Anthropics Life Sciences research team to explore and apply cutting-edge technologies that can accelerate innovation across clinical development.
With support from Anthropic, ICON will develop four production capabilities within Orbis:
Site... More


